文献速递神经肿瘤脊柱脊髓外科

原发性脊髓星形细胞瘤患者生存概率的预后因素与列线图预测

Prognostic factors and nomogram prediction of survival probability in primary spinal cord astrocytoma patients.
PubMed 文献 · J Neurosurg Spine · 2021-08-13

基于SEER数据库纳入468例低级别和165例高级别脊髓星形细胞瘤患者,比较两组流行病学特征,用单因素和多因素分析及Kaplan-Meier曲线确定癌症特异性生存(CSS)和总生存(OS)的风险因素,并构建列线图预测3年、5年和10年CSS和OS率。多因素分析显示低级别组肿瘤延伸距离、手术类型和辅助治疗与CSS独立相关,高级别组肿瘤延伸距离和WHO分级与CSS独立相关;辅助治疗对高级别患者CSS或OS无优势。列线图内部验证CSS的C指数为0.84(95%CI 0.79-0.90)。

要点

  • 低级别脊髓星形细胞瘤中肿瘤延伸距离、手术类型和辅助治疗与CSS独立相关。
  • 高级别脊髓星形细胞瘤中肿瘤延伸距离和WHO分级与CSS独立相关。
  • 辅助治疗对高级别脊髓星形细胞瘤患者的CSS或OS无优势。

核心结论

  • 低级别脊髓星形细胞瘤中肿瘤延伸距离、手术类型和辅助治疗是CSS的显著风险因素。
  • 辅助治疗对高级别脊髓星形细胞瘤患者的CSS或OS无优势。
  • 列线图可能对医疗提供者具有临床实用性。

研究设计与样本

  • 基于SEER数据库的回顾性队列研究,纳入468例低级别和165例高级别脊髓星形细胞瘤患者。
  • 比较两组流行病学特征,用单因素和多因素分析及Kaplan-Meier曲线确定CSS和OS风险因素。
  • 构建列线图预测3年、5年和10年CSS和OS率,用校准图、C指数和时间依赖ROC曲线评估临床实用性。

主要发现

  • 低级别和高级别脊髓星形细胞瘤患者在年龄、肿瘤延伸、保险状态、辅助治疗和生存方面存在差异。
  • 多因素分析显示低级别组肿瘤延伸距离、手术类型和辅助治疗与CSS独立相关。
  • 高级别组肿瘤延伸距离和WHO分级与CSS独立相关。
  • Kaplan-Meier法进一步证实预后变量,并提示辅助治疗对高级别患者无优势。
  • 列线图内部验证CSS的C指数为0.84(95%CI 0.79-0.90)。

关键数值与推荐

  • 列线图内部验证CSS的C指数为0.84(95%CI 0.79-0.90)。

临床怎么用

  • 列线图可用于个体化预测脊髓星形细胞瘤患者3年、5年和10年CSS和OS率。
  • 低级别脊髓星形细胞瘤患者可根据肿瘤延伸距离、手术类型和辅助治疗评估CSS风险。
  • 高级别脊髓星形细胞瘤患者辅助治疗未显示CSS或OS优势,临床决策需综合考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Knowledge on the management of spinal cord astrocytoma (SCA) remains scarce. Here, the authors constructed and validated a predictive nomogram, often used for individualized prognosis and evaluations, to estimate cancer-specific survival (CSS) and overall survival (OS) for patients with SCA. METHODS: Epidemiological characteristics were compared between low-grade SCA (LGSCA) and high-grade SCA (HGSCA) patients from the Surveillance, Epidemiology, and End Results (SEER) database. Risk factors for CSS and OS were determined using univariate and multivariate analyses and Kaplan-Meier curves. A nomogram was developed to individually predict the 3-, 5-, and 10-year CSS and OS rates. The clinical usefulness of the nomogram was assessed using calibration plots, the concordance index (C-index), and time-dependent receiver operating characteristic curves. RESULTS: A total of 468 LGSCA and 165 HGSCA patients were eligible for inclusion. LGSCA and HGSCA patients demonstrated differences in age, tumor extension, insurance status, adjuvant treatment, and survival. Multivariate analysis demonstrated that in the LGSCA group, tumor extension, surgery type, and adjuvant therapy were individually associated with CSS. The distance of tumor extension and WHO grade were individually associated with CSS in the HGSCA group. The prognostic variables were further demonstrated using the Kaplan-Meier method, which also suggested that adjuvant treatment provided no advantage to HGSCA patients. A nomogram was constructed, and the C-index for CSS was 0.84 by internal validation (95% CI 0.79-0.90). CONCLUSIONS: This research suggests that the distance of tumor extension, type of surgery, and adjuvant therapy are significant risk factors for CSS using multivariate analysis in the LGSCA group. Adjuvant treatment provided no advantages for CSS or OS in patients with HGSCAs. The nomogram may be clinically useful to healthcare providers.

来源:J Neurosurg Spine,查看原文。版权归原作者所有。

引用

  1. Yuan C, Yao Q, Cheng L, et al. Prognostic factors and nomogram prediction of survival probability in primary spinal cord astrocytoma patients. J Neurosurg Spine. 2021. PMID: 34388706. doi:10.3171/2021.1.SPINE202017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。